-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M6jwnsQEIAjRBH7KrLV0yXBe63aEnt6wlhoptMYTy//i0povEts+TotgB//1Q2Gx o7rjTEAJWHfUv4Z5lUKhaQ== 0000014272-05-000069.txt : 20050303 0000014272-05-000069.hdr.sgml : 20050303 20050303173348 ACCESSION NUMBER: 0000014272-05-000069 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050301 FILED AS OF DATE: 20050303 DATE AS OF CHANGE: 20050303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DWYER EDWARD M CENTRAL INDEX KEY: 0001217681 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 05658948 BUSINESS ADDRESS: STREET 1: ONE AT&T WAY CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 2125464429 MAIL ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB COMPANY STREET 2: 345 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10154 4 1 dwy362.xml X0202 4 2005-03-01 0 0000014272 BRISTOL MYERS SQUIBB CO (BMY) 0001217681 DWYER EDWARD M 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 Vice President & Treasurer Common Stock, $0.10 par value 2005-03-01 4 A 0 4167 0 A 14167.00 D Option (right to buy) 25.45 2005-03-01 4 A 0 25000 0 A 2015-02-28 Common Stock, $0.10 par value 25000.00 25000.00 D Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. By: /s/ Sonia Vora, Attorney-in-Fact 2005-03-03 -----END PRIVACY-ENHANCED MESSAGE-----